Carlotta Panciera

Mrs. Carlotta Panciera


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2025 in Biosensors
Verified
Journal Article
Open access
PDF file
PCPaola Colapietro
Paola Colapietro
Giuseppe BrunettiGiuseppe Brunetti
Giuseppe Brunetti
CPCarlotta Panciera
Carlotta Panciera
AEAurora Elicio
Aurora Elicio
Caterina CiminelliCaterina Ciminelli
Caterina Ciminelli
Liquid biopsy (LB) has gained attention as a valuable approach for cancer diagnostics, providing a minimally invasive option compared to conventional tissue biopsies and helping to overcome issues related to patient discomfort and procedural invasiveness. Recent advances in biosensor technologies, particularly photonic sensors, have improved the accuracy, speed, and real-time capabilities for detecting circulating biomarkers in biological fluids. Incorporating these tools into clinical practice facilitates more informed therapeutic choices and contributes to tailoring treatments to individual patient profiles. This review highlights the clinical potential of LB, examines technological limitations, and outlines future research directions. Departing from traditional biosensor focused reviews, it adopts a reverse-mapping approach grounded in clinically relevant tumor biomarkers. Specifically, biomarkers associated with prevalent cancers, such as breast, prostate, and lung cancers, serve as the starting point for identifying the most suitable photonic sensing platforms. The analysis underscores the need to align sensor design with the physicochemical properties of each biomarker and the operational requirements of the application. No photonic platform is universally optimal; rather, each exhibits specific strengths depending on performance metrics such as sensitivity, limit of detection, and easy system integration. Within this framework, the review provides a comprehensive assessment of emerging photonic biosensors and outlines key priorities to support their effective clinical translation in cancer diagnostics.

14 August 2026 in Biosensors
Verified
Journal Article
Open access
PDF file
CPCarlotta Panciera
Carlotta Panciera
Giuseppe BrunettiGiuseppe Brunetti
Giuseppe Brunetti
Caterina CiminelliCaterina Ciminelli
Caterina Ciminelli
Muhammad Ali ButtMuhammad Ali Butt
Muhammad Ali Butt
A hybrid metasurface absorber (MSA) based on a central-bar-coupled split-disk dimer is proposed and numerically investigated for high-resolution refractive-index sensing in the near-infrared spectral region. The metasurface consists of silicon nitride dielectric resonators integrated with a gold plasmonic layer, enabling strong electromagnetic confinement, enhanced light–matter interaction, and ultra-narrow resonant features within the 1000–1400 nm wavelength range. The optimized structure supports multiple resonant modes under both x- and y-polarized excitation, producing sharp reflection dips with full-width-at-half-maximum values as low as 0.58 nm and quality factors reaching 2007. Refractive-index sensing performance was evaluated by varying the aqueous superstrate refractive index from 1.33 to 1.35, resulting in bulk sensitivities up to 860 nm/RIU under normal incidence. The angular response was further analyzed for incidence angles up to 5°, revealing polarization-dependent resonance splitting and the emergence of additional high-Q resonant branches under oblique excitation. Several angularly induced resonances exhibit narrower linewidths than those observed at normal incidence while preserving high refractive-index sensitivity up to 870 nm/RIU. Electric-field distributions confirm strong field localization near the dielectric boundaries and coupling regions, validating the hybrid resonant mechanism responsible for the enhanced spectral selectivity and sensing performance. The proposed MSA provides a promising platform for compact and ultrasensitive biosensing applications.